✦ LIBER ✦

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center

✍ Scribed by Tsai, S. B.; Seldin, D. C.; Quillen, K.; Berk, J. L.; Ruberg, F. L.; Meier-Ewert, H.; Sloan, J. M.; Doros, G.; Finn, K. T.; Skinner, M.; Sanchorawala, V.

Book ID: 118041360
Publisher: American Society of Hematology
Year: 2012
Tongue: English
Weight: 161 KB
Volume: 120
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2012-09-457341

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment-Related Mortality in Patients

✍ V. Sanchorawala; M. Skinner; K.T. Finn; K. Quillen; D.C. Seldin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

High-dose idarubicin, cyclophosphamide a

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB